Sulfonamido-2-arylbenzoxazole GroEL/ES Inhibitors as Potent Antibacterials against Methicillin-Resistant Staphylococcus aureus (MRSA)-Reference-Cited by-同舟云学术

Sulfonamido-2-arylbenzoxazole GroEL/ES Inhibitors as Potent Antibacterials against Methicillin-Resistant Staphylococcus aureus (MRSA)

Published:2018-07-30 Issue:16 Volume:61 Page:7345-7357
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Abdeen Sanofar¹,Kunkle Trent¹,Salim Nilshad¹,Ray Anne-Marie¹,Mammadova Najiba¹,Summers Corey¹,Stevens Mckayla¹,Ambrose Andrew J.²^ORCID,Park Yangshin¹³⁴,Schultz Peter G.⁵^ORCID,Horwich Arthur L.⁶,Hoang Quyen Q.¹³⁴,Chapman Eli²,Johnson Steven M.¹^ORCID

Affiliation:

1. Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, 635 Barnhill Drive, Indianapolis, Indiana 46202, United States

2. College of Pharmacy, Department of Pharmacology and Toxicology, The University of Arizona, 1703 East Mabel Street, P.O. Box 210207, Tucson, Arizona 85721, United States

3. Stark Neurosciences Research Institute, Indiana University School of Medicine, 320 West 15th Street, Suite 414, Indianapolis, Indiana 46202, United States

4. Department of Neurology, Indiana University School of Medicine, 635 Barnhill Drive, Indianapolis, Indiana 46202, United States

5. Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States

6. HHMI, Department of Genetics, Yale School of Medicine, Boyer Center for Molecular Medicine, 295 Congress Avenue, New Haven, Connecticut 06510, United States

Funder

Howard Hughes Medical Institute

University of Arizona

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b00989

Reference36 articles.

1. Tacconelli, E.; Magrini, N. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics; World Health Organization: Geneva, Switzerland, 2017; p 7.

2. Centers for Disease Control and Prevention Antibiotic Resistance Threats in the United States, 2013; Centers for Disease Control and Prevention: Atlanta, Georgia, 2013; p 114.

3. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia–Pacific countries: SMART 2013–2015

4. Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens

5. Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combatting resistance: Understanding multi-drug resistant pathogens in intensive care units;Biomedicine & Pharmacotherapy;2023-11

2. Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol;Bioorganic & Medicinal Chemistry;2022-12

3. Recent Advances in Biological Active Sulfonamide-based Hybrid Compounds Part C: Multicomponent Sulfonamide Hybrids;Current Medicinal Chemistry;2022-11-28

4. Synthesis and Characterization of 2‐(2‐((1‐Aryl‐1H‐1,2,3‐triazol‐4‐yl)methoxy)phenyl)benzoxazoles: Evaluation of Cytotoxicity and Antioxidant Activity;ChemistrySelect;2022-11-16

5. Ionic liquid-functionalised AlPO-34 material prepared by ionothermal method for efficient antibacterial property against Escherichia coli;Materials Research Innovations;2022-07-05